These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14484649)

  • 1. Toxic effects of high doses of protamine sulphate, with special reference to the kidneys.
    PAVONE M
    Panminerva Med; 1962 Jan; 4():4-8. PubMed ID: 14484649
    [No Abstract]   [Full Text] [Related]  

  • 2. Protamine sulphate-induced proteinuria: the roles of glomerular injury and depletion of polyanion.
    Messina A; Davies DJ; Ryan GB
    J Pathol; 1989 Jun; 158(2):147-56. PubMed ID: 2754545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FINDINGS ON DIABETIC NEPHROPATHY. I. EXPERIMENTAL REPRODUCTION IN A DIABETIC-LIKE PICTURE IN KIDNEYS OF RABBITS TREATED WITH PROTAMINE].
    LENTI G; PELLEGRINI A; SIRIGU F
    Rass Med Sarda; 1965; 68():167-81. PubMed ID: 14339847
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the pathogenesis of diabetic nephropathy. Electron microscopic findings in the kidneys of animals treated with protamine].
    Lenti G; Pellegrini A; Sirigu F; Pagano G
    Minerva Med; 1966 Aug; 57(69):2785-9. PubMed ID: 5918094
    [No Abstract]   [Full Text] [Related]  

  • 5. Glomerular albumin leakage and morphology after neutralization of polyanions. II. Discrepancy of protamine induced albuminuria and fine structure of the glomerular filtration barrier.
    Sonnenburg-Hatzopoulos C; Assel E; Schurek HJ; Stolte H
    J Submicrosc Cytol; 1984 Oct; 16(4):741-51. PubMed ID: 6209419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protamine and mast-cell-mediated angiogenesis in the rat.
    Jakobsson A; Sörbo J; Norrby K
    J Exp Pathol (Oxford); 1990 Apr; 71(2):209-17. PubMed ID: 1691920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation caused by protamine sulfate].
    CAPRI A; BOMBARA G
    Boll Soc Ital Biol Sper; 1961 Apr; 37():366-8. PubMed ID: 13690628
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    Surgery; 1959 Dec; 46():1060-8. PubMed ID: 13793331
    [No Abstract]   [Full Text] [Related]  

  • 9. Protamine: a cardiotoxic agent with negative inotropism.
    Lee T; Lin Y
    Anesthesiology; 1991 Mar; 74(3):635. PubMed ID: 2001050
    [No Abstract]   [Full Text] [Related]  

  • 10. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protamine-induced pulmonary edema in rats.
    Koslow AR; DeFouw DO; Farid MD; Curl GR; Shumko JZ; Feinberg RN; Hobson RW
    Curr Surg; 1987; 44(3):219-24. PubMed ID: 3595204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on the pathogenesis of diabetic nephropathies. Further studies on nephropathy induced in animals by protamine sulfate].
    Lenti G; Pellegrini A; Sirigu F; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1967 May; 58(40):1872-6. PubMed ID: 6026392
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON SOME EFFECTS ON PERIPHERAL BLOOD AND BONE MARROW CAUSED BY REPEATED TREATMENT WITH PROTAMINE SULFATE].
    CAPRI A; ORECCHIO F; TETI M; MASTROENI P
    Haematologica; 1963; 48():591-612. PubMed ID: 14160412
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [RETINAL ATHEROSCLEROSIS. FUNCTIONAL MODIFICATIONS WITH THE USE OF AN AMINOCOMPLEX DERIVED FROM PROTAMINE].
    YANKELEVICH IJ
    Sem Med; 1963 Dec; 123():1951-5. PubMed ID: 14128156
    [No Abstract]   [Full Text] [Related]  

  • 17. Protamine sulphate and heparin rebound following open-heart surgery.
    Kesteven PJ; Ahmed A; Aps C; Williams BT; Savidge GF
    J Cardiovasc Surg (Torino); 1986; 27(5):600-3. PubMed ID: 3760024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECT OF PROTAMINE SULPHATE ON THE TRANSMISSION PROCESSES IN PERIPHERAL SYMPATHETIC GANGLIA.
    MINKER E; KOLTAI M
    Acta Physiol Acad Sci Hung; 1964; 24():365-71. PubMed ID: 14159894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Does cignolin have a toxic effect on the kidneys?].
    IPPEN H
    Arch Klin Exp Dermatol; 1960; 211():310-3. PubMed ID: 13852957
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the pathogenesis of diabetic nephropathy. Experimental histochemical, optical microscopic and biochemical studies in animals treated with protamine sulfate].
    Lenti G; Pellegrini A; Sirigu F; Pagano G; Riva A
    Minerva Med; 1966 Aug; 57(69):2789-95. PubMed ID: 5331310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.